Invest in Regeneration

Orthocell Investor Centre

Orthocell is a publicly-traded company listed on the Australian Securities Exchange (ASX:OCC).

OCC Share Price

View all announcements here.

18 April 2023 | Veritas Securities Ltd | Analyst ReportDownload Report
13 June 2023 | Petra Capital – ‘Providing innovative tools for surgical success; Buy, A$1.21tgt’ – Analyst, Tanushree Jain.
For a copy of this analyst report please contact your Petra Advisor.

Latest Financial Report

Remuneration and Nomination Committee CharterDownload document
Appendix 4G
Download document
Corporate Governance StatementDownload document
Board charterDownload document
Code of conductDownload document
Orthocell ConstitutionDownload document
Employee Equity Incentive PlanDownload document
Privacy PolicyDownload document
Securities Trading PolicyDownload document
Whistleblower policyDownload document
Anti-bribery and corruption policyDownload document
Continuous disclosure policyDownload document
Diversity policyDownload document
Purposes and values policyDownload document

Right to receive documentsView

"Our Company is pursuing a total addressable market for our dental, nerve and autologous tendon therapy products of US$17.7 billion per annum – a compelling investment and growth opportunity."

Orthocell MD, Paul Anderson

Latest news

News updates, straight to your inbox